LAS VEGAS--(BUSINESS WIRE)--Sterling-Hoffman Life Sciences Journal spotlights Dr. Janet Greeson, CEO of Samaritan Pharmaceuticals (OTCBB:SPHC) (http://www.samaritanpharma.com), a biopharmaceutical company committed to commercializing new innovative therapeutic drugs.
